FFO
APGE icon

Fortitude Family Office’s Apogee Therapeutics APGE Stock Holding History

Fortitude Family Office’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12K Buy
+16
New +$1.44K ﹤0.01% 1466

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Fortitude Family Office's APGE Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 16 shares worth $2.12K. The stake represents ﹤0.01% of the portfolio and ranks #1466 among its holdings.

20 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Fortitude Family Office held 16 shares of Apogee Therapeutics worth $2.12K as of Q2 2026.
  • Apogee Therapeutics was a new Fortitude Family Office position in Q2 2026.
  • Apogee Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1466 holding.
  • 20 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.